SG Americas Securities LLC Makes New Investment in Enfusion, Inc. (NYSE:ENFN)

SG Americas Securities LLC purchased a new stake in Enfusion, Inc. (NYSE:ENFN - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 94,032 shares of the company's stock, valued at approximately $892,000. SG Americas Securities LLC owned approximately 0.07% of Enfusion as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the stock. Wasatch Advisors LP raised its holdings in shares of Enfusion by 34.2% in the first quarter. Wasatch Advisors LP now owns 792,083 shares of the company's stock valued at $7,327,000 after purchasing an additional 201,771 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Enfusion by 57.5% in the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company's stock valued at $4,466,000 after purchasing an additional 191,436 shares during the last quarter. Scalar Gauge Management LLC raised its holdings in shares of Enfusion by 21.8% in the second quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company's stock valued at $5,227,000 after purchasing an additional 110,000 shares during the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Enfusion in the second quarter valued at approximately $683,000. Finally, Renaissance Technologies LLC raised its holdings in shares of Enfusion by 167.6% in the second quarter. Renaissance Technologies LLC now owns 97,100 shares of the company's stock valued at $827,000 after purchasing an additional 60,811 shares during the last quarter. Institutional investors own 81.05% of the company's stock.

Enfusion Stock Performance

ENFN traded up $0.04 during trading on Friday, reaching $8.99. 166,282 shares of the stock were exchanged, compared to its average volume of 374,688. The stock has a market cap of $1.15 billion, a P/E ratio of 224.81, a price-to-earnings-growth ratio of 2.49 and a beta of 0.92. Enfusion, Inc. has a twelve month low of $7.52 and a twelve month high of $10.45. The stock's 50 day moving average price is $8.49 and its two-hundred day moving average price is $8.89.

Enfusion (NYSE:ENFN - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by ($0.01). The firm had revenue of $49.46 million for the quarter, compared to analyst estimates of $50.27 million. Enfusion had a return on equity of 6.17% and a net margin of 1.98%. Equities research analysts predict that Enfusion, Inc. will post 0.07 earnings per share for the current fiscal year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.